Thermo Fisher Scientific Inc. (NYSE:TMO) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. Noting the market’s reaction to the company’s recently reported quarter, Cramer said:
Alright, what just happened to the stock of Thermo Fisher Scientific, the arms dealer to the life sciences industry that I’ve liked for so long? This morning, Thermo Fisher reported what looks like a very solid set of numbers, a modest revenue beat paired with a healthy 19-cent earnings beat off a $5.25 basis. Management also raised their full-year forecast substantially, but their guidance for the current quarter came in light. In response, the stock got obliterated today, plunging $47.28 or 9.2% to the point where the stock’s now down nearly 20%… I think that the market has this wrong… This is a great American company.
A stock market graph. Photo by energepic.com
Thermo Fisher Scientific Inc. (NYSE:TMO) provides instruments, reagents, consumables, software, and lab services that support scientific research, diagnostics, and drug and vaccine development.
While we acknowledge the potential of TMO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years
Disclosure: None. Follow Insider Monkey on Google News.
